Global Antiviral Drugs Market Research Report 2021

1 Antiviral Drugs Market Overview

• 1.1 Product Overview and Scope of Antiviral Drugs
• 1.2 Antiviral Drugs Segment by Type
  • 1.2.1 Global Antiviral Drugs Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Reverse Transcriptase Inhibitors
  • 1.2.3 Protease Inhibitors
  • 1.2.4 Fusion Inhibitors
  • 1.2.5 Immune System Modulators
• 1.3 Antiviral Drugs Segment by Application
  • 1.3.1 Antiviral Drugs Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hepatitis Therapeutics
  • 1.3.3 HIV/AIDS Therapeutics
  • 1.3.4 Herpes Therapeutics
  • 1.3.5 Influenza Therapeutics
• 1.4 Global Antiviral Drugs Market Size Estimates and Forecasts
  • 1.4.1 Global Antiviral Drugs Revenue 2016-2027
  • 1.4.2 Global Antiviral Drugs Sales 2016-2027
  • 1.4.3 Antiviral Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antiviral Drugs Market Competition by Manufacturers

• 2.1 Global Antiviral Drugs Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Antiviral Drugs Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Antiviral Drugs Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Antiviral Drugs Manufacturing Sites, Area Served, Product Type
• 2.5 Antiviral Drugs Market Competitive Situation and Trends
  • 2.5.1 Antiviral Drugs Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Antiviral Drugs Players Market Share by Revenue
  • 2.5.3 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antiviral Drugs Retrospective Market Scenario by Region

• 3.1 Global Antiviral Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Antiviral Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Antiviral Drugs Market Facts & Figures by Country
  • 3.3.1 North America Antiviral Drugs Sales by Country
  • 3.3.2 North America Antiviral Drugs Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Antiviral Drugs Market Facts & Figures by Country
  • 3.4.1 Europe Antiviral Drugs Sales by Country
  • 3.4.2 Europe Antiviral Drugs Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Antiviral Drugs Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Antiviral Drugs Sales by Region
  • 3.5.2 Asia Pacific Antiviral Drugs Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Antiviral Drugs Market Facts & Figures by Country
  • 3.6.1 Latin America Antiviral Drugs Sales by Country
  • 3.6.2 Latin America Antiviral Drugs Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Antiviral Drugs Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Antiviral Drugs Sales by Country
  • 3.7.2 Middle East and Africa Antiviral Drugs Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Antiviral Drugs Historic Market Analysis by Type

• 4.1 Global Antiviral Drugs Sales Market Share by Type (2016-2021)
• 4.2 Global Antiviral Drugs Revenue Market Share by Type (2016-2021)
• 4.3 Global Antiviral Drugs Price by Type (2016-2021)

5 Global Antiviral Drugs Historic Market Analysis by Application

• 5.1 Global Antiviral Drugs Sales Market Share by Application (2016-2021)
• 5.2 Global Antiviral Drugs Revenue Market Share by Application (2016-2021)
• 5.3 Global Antiviral Drugs Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Roche Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Johnson & Johnson
  • 6.2.1 Johnson & Johnson Corporation Information
  • 6.2.2 Johnson & Johnson Description and Business Overview
  • 6.2.3 Johnson & Johnson Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Johnson & Johnson Product Portfolio
  • 6.2.5 Johnson & Johnson Recent Developments/Updates
• 6.3 Merck
  • 6.3.1 Merck Corporation Information
  • 6.3.2 Merck Description and Business Overview
  • 6.3.3 Merck Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Merck Product Portfolio
  • 6.3.5 Merck Recent Developments/Updates
• 6.4 Novartis
  • 6.4.1 Novartis Corporation Information
  • 6.4.2 Novartis Description and Business Overview
  • 6.4.3 Novartis Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Novartis Product Portfolio
  • 6.4.5 Novartis Recent Developments/Updates
• 6.5 Bristol-Myers Squibb
  • 6.5.1 Bristol-Myers Squibb Corporation Information
  • 6.5.2 Bristol-Myers Squibb Description and Business Overview
  • 6.5.3 Bristol-Myers Squibb Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Bristol-Myers Squibb Product Portfolio
  • 6.5.5 Bristol-Myers Squibb Recent Developments/Updates
• 6.6 Gilead Sciences
  • 6.6.1 Gilead Sciences Corporation Information
  • 6.6.2 Gilead Sciences Description and Business Overview
  • 6.6.3 Gilead Sciences Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Gilead Sciences Product Portfolio
  • 6.6.5 Gilead Sciences Recent Developments/Updates
• 6.7 GlaxoSmithKline
  • 6.6.1 GlaxoSmithKline Corporation Information
  • 6.6.2 GlaxoSmithKline Description and Business Overview
  • 6.6.3 GlaxoSmithKline Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 GlaxoSmithKline Product Portfolio
  • 6.7.5 GlaxoSmithKline Recent Developments/Updates
• 6.8 AbbVie
  • 6.8.1 AbbVie Corporation Information
  • 6.8.2 AbbVie Description and Business Overview
  • 6.8.3 AbbVie Antiviral Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 AbbVie Product Portfolio
  • 6.8.5 AbbVie Recent Developments/Updates

7 Antiviral Drugs Manufacturing Cost Analysis

• 7.1 Antiviral Drugs Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Antiviral Drugs
• 7.4 Antiviral Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Antiviral Drugs Distributors List
• 8.3 Antiviral Drugs Customers

9 Antiviral Drugs Market Dynamics

• 9.1 Antiviral Drugs Industry Trends
• 9.2 Antiviral Drugs Growth Drivers
• 9.3 Antiviral Drugs Market Challenges
• 9.4 Antiviral Drugs Market Restraints

10 Global Market Forecast

• 10.1 Antiviral Drugs Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Antiviral Drugs by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Antiviral Drugs by Type (2022-2027)
• 10.2 Antiviral Drugs Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Antiviral Drugs by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Antiviral Drugs by Application (2022-2027)
• 10.3 Antiviral Drugs Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Antiviral Drugs by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Antiviral Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List